A Bridge Project-supported collaboration between KI members Darrell Irvine and Bradley Pentelute, and Dana-Farber Cancer Institute’s Catherine Wu and David Reardon, suggests a strategy to boost efficacy of peptide vaccines in combination immunotherapies. Their approach, described in PNAS, increased T cell priming in lymph nodes through improved accumulation, trafficking, stability, and exposure.